Actinium Pharmaceuticals 10K 2014 Annual report | ATNM Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Abbivie, abbreviated, AbbVie, abstr, abuse, adapt, added, al, Albert, ASH, ASU, Atomic, Atossa, attend, attended, attorney, Baylor, BeginningJanuary, biosimilar, BPCIA, brand, branded, clarify, cleanup, Clin, collateral, College, Columbia, comment, complicating, comprising, conduit, Congressional, credible, CRO, curtailment, cytoreduction, dealt, debated, deducting, defraud, denial, depriving, distinction, DOTA, DSMB, Edison, Einstein, establishedin, exposed, feasibility, float, footnote, fraudulent, function, GAAP, gap, GBH, GCP, Glioblastoma, guidance, guiding, headcount, higher, hinder, HIPAA, HITECH, hurt, implanted, imprisonment, incidence, infused, inhaled, inhibit, inInternal, injected, instilled, interchangeable, interrupt, intrinsic, ix, jeopardized, JG, Jurcic, McDevitt, meantime, Med, methodology, misuse, MLV, monotherapy, multi, Multiforme, myloma, nanocurie, nonclinical, Oncol, orientation, outpatient, pain, paragraph, pathway, physicochemical, pollution, Portability, Postgrad, potency, Prepaid, prescription, privacy, qualitative, questioned, rare, rebate, reexamination, referral, repeat, resubmit, Rosenblat, salvage, scheme, science, send, Sequential, shelf, shortage, statute, stay, stopped, store, strict, sublease, sublicense, subsection, Subtopic, sued, sunshine, superior, suppl, teaching, tenant, Thornall, ticker, TL, transmission, Tumor, unannounced, undepreciated, Undesirable, unforeseen, unqualified, unreliable, varying, VIE, vii, viii, vitro, waste, wealth, willfully, worldwide, wrote, yearly, Yeshiva

Removed: Button, computed, decline, deficiency, Diane, employer, exceeded, expert, maturity, nominated, otcbb, preemptive, presently, qualify, reportable, residence, restriction, signature, suitability

Actinium Pharmaceuticals (ATNM) 10-K2014 FY Annual report

Content analysis